Web Watch

Figures converted from INR at historical FX rates — see data/company.json.fx_rates (FY2025 ≈ 0.0117 USD/INR; FY2026 ≈ 0.01066; spot 2026-06-05 = 0.01044). Ratios, margins, and multiples are unitless and unchanged.

Web Watch in One Page

Five live monitors cover the questions that drive Rajesh Exports Limited over the next 12-36 months. The 03-Jun-2026 SEBI ex-parte interim order has narrowed the debate from "0.17× P/B value trap or asset-backed mispricing?" toward whether the listing structure that holds Valcambi is preserved intact. Monitor #1 tracks every node of the SEBI / SAT / NFRA process. Monitor #2 watches the auditor change cascade, which would force prior-year restatement under most plausible scenarios. Monitor #3 sits on the Valcambi asset itself — a standalone P&L disclosure would resolve much of the gross-vs-net dispute in one document, and any LBMA accreditation action would materially impair the asset moat. Monitor #4 flags pledge or sale activity on the Mehta family stake and any acceleration in the slow FII trim. Monitor #5 reads each quarterly filing through the same lens SEBI is applying — the offshore Investments line, the standalone-vs-consolidated split, the Other-Income bridge over operating losses. The set is built for an investor whose conviction depends on disclosures the company has not yet been willing to make and on a regulatory process whose timeline to a final order is uncertain.

Active Monitors

Rank	Watch item	Cadence	Why it matters	What would be detected
1	SEBI / SAT / NFRA regulatory process	Daily	The 03-Jun-2026 ex-parte interim order alleges ~$162B-$180B of consolidated revenue misstatement across FY2021-FY2025 (₹15.15 lakh crore at FY25/FY26 FX) and ~$99M-$108M of promoter-linked flows (₹926 crore) undisclosed as related-party transactions. The order is binary for the listing structure; every other variable re-prices around it.	Company's reply to the 30-day window (closes on or about 03-Jul-2026), any modification or vacation of the interim order, SAT or Bombay High Court appeals by Rajesh Mehta, appointment and findings of the fresh forensic audit ordered by SEBI (the earlier BDO engagement reported denied ERP access), NFRA action against statutory auditor BSD & Co.
2	Statutory auditor change and Audit Committee response	Daily	A Big-Four firm accepting the engagement with a clean opinion on restated accounts is one of the few paths to institutional re-rating; continued BSD & Co. tenure would extend the holding-company discount.	BSD & Co. resignation or removal, appointment of a Big-Four successor, Audit Committee independent inquiry, qualification or withdrawal of prior-year opinions on FY21-FY26 consolidated financials, NFRA sanctions on BSD & Co. partners.
3	Valcambi standalone disclosure and LBMA accreditation	Weekly	Valcambi is the only High-proof-quality moat source in the report and the entire SOTP floor; a published standalone P&L would resolve much of the SEBI gross-vs-net dispute in one document, while any LBMA accreditation action would materially impair the asset moat.	Valcambi SA standalone P&L or treatment-fee × tonnage disclosure in annual report Annexure III or Swiss commercial register (Zefix, Moneyhouse); LBMA Good Delivery suspension or delisting; Responsible Sourcing audit findings; Russian-gold or conflict-zone provenance scandal; segment carve-out, partial Swiss listing, or strategic sale.
4	Promoter pledge, SAST disclosures, and shareholding pattern	Daily	The Mehta family's 54.55% stake (held at this level since Mar 2024; 53.94%-54.05% prior) has no externally confirmed pledge status; any first pledge or SAST sale into a tape that trades roughly $144K/day on 20-day average (₹1.38 crore) would be among the cleanest survival-vs-distress signals available.	Pledge or encumbrance filings under SAST Regulation 31, market or off-market promoter transactions under Regulation 7(2) or 29(2), quarterly shareholding pattern changes (FII baseline 14.26% as of Mar 2026), CDSL or NSDL pledge disclosures on ISIN INE343B01030, new substantial-shareholder appearances or exits.
5	Quarterly results, Investments line, and capital-return signals	Daily	The Investments line — ~$1.26B at FY26 close (₹11,797 crore), roughly 4.0× the ~$316M market cap (₹2,962 crore) — is the largest single capital-allocation question for the next decade; each quarterly filing tests whether the offshore book is growing, shrinking, or being clarified, and whether the Other-Income-bridges-operating-loss pattern persists under regulatory scrutiny.	Standalone and consolidated quarterly filings with attention to the Investments line trajectory, Other Liabilities (~$2.41B at FY26 close, ₹22,608 crore), Other Income vs operating profit, standalone-vs-consolidated revenue split, related-party transaction disclosures, Shubh retail and ACC battery updates, dividend or buyback resumption, restatement of prior-year accounts, resumption of investor calls.

Why These Five

Each monitor maps to one of the report's open questions that an investor cannot answer from public information available today. The verdict — Avoid — is conditional on the conjunction of (a) the SEBI order vacated on substance and (b) publication of a Valcambi SA standalone P&L with audited reconciliation to consolidated revenue. Monitor #1 watches for (a); monitor #3 watches for (b). Monitor #2 covers the structural event that would force prior-year restatement under most plausible scenarios — the textbook precedent is an NFRA-driven auditor change. Monitor #4 isolates a near-term survival signal in a microcap tape that cannot absorb a forced promoter sale. Monitor #5 reads every new financial filing through the same earnings-quality lens the regulator is now applying — the offshore Investments line, the standalone-vs-consolidated gap, the Other-Income-over-operating-profit bridge. None of these five questions has a derivable answer from price action or analyst coverage; each requires a specific filing, order, or disclosure to land. The set is built so that any high-information event over the next 12-36 months hits at least one monitor.